Investors

Webcast ImageWebcast
ObsEva at the BMO Healthcare Conference  (Replay)
12 Dec 2018 at 2:00 p.m. ET
ObsEva at the BMO Healthcare Conference
Wednesday, December 12, 2018 2:00 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast
R&D Investor Day (Replay)
07 Dec 2018 at 8:30 a.m. ET
R&D Investor Day
Friday, December 7, 2018 8:30 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar

Founded in November 2012, ObsEva is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman’s reproductive health and pregnancy. We believe our expertise has led to the development of new and innovative therapies that have the potential to improve patient outcomes in reproductive health.

Events

07 Dec 2018 8:30 a.m. ETR&D Investor Day
04 Mar 2019Week of March 4, 2019 : Full year 2018 financial results
View all

Featured Presentation

15 Nov 2018
ObsEva Investor Presentation - November 2018  PDF
08 Nov 2018
Q3 Report 2018 PDF
08 Aug 2018
Half-Year Report 2018 PDF
16 May 2018
Q1 Report 2018 PDF
16 Apr 2018
Annual Report 2017 PDF
14 Nov 2017
Q3 Report 2017  PDF
16 Aug 2017
Q2 Report 2017  PDF
18 May 2017
Q1 Report 2017  PDF
21 Apr 2017
Annual Report 2016 PDF

Stock Information

For investor relations, please contact:
IR@obseva.ch